Francesca Coperchini
Biologo

Contatta il professionista
Specializzazione
  • Biologia
  • Patologia Clinica (per non medici)
  • Rotondi M, Coperchini F, Pignatti P, Sideri R, Groppelli G, Leporati P, La Manna L, Magri F, Mariotti S, Chiovato L. Interferon-γ and Tumor Necrosis Factor-α Sustain Secretion of Specific CXC Chemokines in Human Thyrocytes: A First Step Toward a Differentiation between Autoimmune and Tumor-Related Inflammation? J Clin Endocrinol Metab. 2013 98(1):308-13.
  • Coperchini F, Pignatti P, Lacerenza S, Negri S, Sideri R, Testoni C, de Martinis L, Cottica D, Magri F, Imbriani M, Rotondi M, Chiovato L. Exposure to perfluorinated compounds: in vitro study on thyroid cells. Environ Sci Pollut Res Int. 2015 Feb;22(3):2287-94.
  • Rotondi M., Coperchini F., Pignatti P., Magri F., Chiovato L. Metformin Reverts the Secretion of CXCL8 Induced by TNF-α in Primary Cultures of Human Thyroid Cells: An Additional Indirect Anti-Tumor Effect of the Drug. J Clin Endocrinol Metab. 2015  J Clin Endocrinol Metab. 2015 Mar;100(3):E427-32.
  • Coperchini F, Leporati P, Rotondi M, Chiovato L. Expanding the therapeutic spectrum of metformin: from diabetes to cancer. J Endocrinol Invest. 2015 Oct;38(10):1047-55. doi: 10.1007/s40618-015-0370-z. Epub 2015 Aug 2.
  • Coperchini F, Pignatti P, Leporati P, Carbone A, Croce L, Magri F, Chiovato L, Rotondi M. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion. Endocrine. 2016 Oct;54(1):123-128.
  • Coperchini F, Awwad O, Rotondi M, Santini F, Imbriani M, Chiovato L. Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). J Endocrinol Invest. 2017 Feb;40(2):105-121.
  • Rotondi M, Coperchini F, Latrofa F, Chiovato L. Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? Front Endocrinol (Lausanne). 2018 Jun 21;9:314.
  • Coperchini F, Croce L, Denegri M, Awwad O, Tata ST , Muzza M, Capelli V, Latrofa F, Persani L, Chiovato, Rotondi M. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors. Sci Rep 2019
  • Coperchini F, Croce L, Denegri M, Pignatti P, Agozzino M, Netti GS, Imbriani M, Rotondi M, Chiovato L. (2020). Adverse Effects of in Vitro GenX Exposure on Rat Thyroid Cell Viability, DNA Integrity and Thyroid-Related Genes Expression. ENVIRONMENTAL POLLUTION, ISSN: 0269-7491
  • Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. (2020). The Cytokine Storm in COVID-19: An Overview of the Involvement of the chemokine/chemokine-receptor System. CYTOKINE & GROWTH FACTOR REVIEWS, ISSN: 1359

Presta servizio in queste sedi

Profili simili


GH4T12Fv7resHnpU